Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02219399 · ClinicalTrials.gov registry record · NA
DHA Supplementation and Pregnancy Outcome
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 871
- Enrollment target
NCT02219399: Completed NA study, sponsored by Colorado State University.
NCT02219399 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 871 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02219399, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 871 participants
- Enrollment target
Study Summary
Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.
Primary Outcome
Length of gestation as measured by Last menstrual period method and US
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 600 mg DHA
- DIETARY_SUPPLEMENT 300 mg DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 871 participants |
| Start Date | 2001-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT02219399 record still lists
NCT02219399 is an interventional study that assigns participants to a tested intervention. The registered 871 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02219399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02219399 about?
NCT02219399 is a clinical study titled "DHA Supplementation and Pregnancy Outcome". Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.
What is the current status of trial NCT02219399?
This trial is currently completed. It is a NA study. The enrollment target is 871 participants. The study started on 2001-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02219399?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 600 mg DHA (DIETARY_SUPPLEMENT), 300 mg DHA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02219399?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02219399's enrollment target sits among peer trials
871 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia